Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 9 matching records.
9 results — page 1 of 1
- Level ASystematic ReviewEurope PMC
Intranasal administration of stem cells and their derivatives for neurological and respiratory disorders: a systematic review of human clinical trials
Systematic Review with a reported sample of 104 on Systemic / IV, published in Front Aging Neurosci (2026) — summary generated from the PubMed abstract.
- 2026
- n = 104
Front Aging Neurosci - Level DAnimal StudyPubMed
Intranasal administration of exosomes derived from adipose mesenchymal stem cells ameliorates depressive-like behaviors and inhibits inflammation via AMPK/mTOR-mediated autophagy.
Animal Study on Neuroinflammation, published in J Affect Disord (2025) — summary generated from the PubMed abstract.
- 2025
J Affect Disord - Level AMeta-analysisPubMed
Intranasal administration of stem cell derivatives for the treatment of AD animal models: a systematic review and meta-analysis.
Meta-analysis on Neuroinflammation, Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther4 citations - Level BClinical TrialPubMed
Intranasal Administration of Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Has Therapeutic Effect in Experimental Autoimmune Encephalomyelitis.
Clinical Trial on Neuroinflammation, Immune Modulation, Autoimmune Research, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
Cells5 citations - Level DLaboratory StudyEurope PMC
Therapeutic Effects of Intranasal Administration of Mesenchymal Stem Cell-Derived Secretome in Rats Exposed to Chronic Unpredictable Mild Stress
Laboratory Study on Neuroinflammation, Chronic Inflammation, published in Pharmaceutics (2025) — summary generated from the PubMed abstract.
- 2025
Pharmaceutics1 citations - Level BClinical TrialPubMed
The short-term and long-term effects of intranasal mesenchymal stem cell administration to noninflamed mice lung.
Clinical Trial on Chronic Inflammation, published in Front Immunol (2022) — summary generated from the PubMed abstract.
- 2022
Front Immunol - Level DLaboratory StudyPubMed
Can Intranasal Administration of Adipose-Derived Stem Cells Reach and Affect the Histological Structure of Distant Organs of Aged Wistar Rat?
Laboratory Study on Systemic / IV, published in J Microsc Ultrastruct (2022) — summary generated from the PubMed abstract.
- 2022
J Microsc Ultrastruct - Level DAnimal StudyPubMed
Intranasal Administration of Mesenchymal Stem Cell Secretome Reduces Hippocampal Oxidative Stress, Neuroinflammation and Cell Death, Improving the Behavioral Outcome Following Perinatal Asphyxia.
Animal Study on Neuroinflammation, published in Int J Mol Sci (2020) — summary generated from the PubMed abstract.
- 2020
Int J Mol Sci - Level DAnimal StudyPubMed
Intranasal mesenchymal stem cell secretome administration markedly inhibits alcohol and nicotine self-administration and blocks relapse-intake: mechanism and translational options.
Animal Study on Neuroinflammation, Chronic Inflammation, published in Stem Cell Res Ther (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cell Res Ther
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406